AbbVie Stock ABBV · Forecast & Analysis
Heads-up: USD Core Retail Sales m/m, Retail Sales m/m are due in 21 h (high impact). The outlook can shift noticeably around them.
AbbVie (ABBV) reads neutral: the only fresh news is a small set of positive aesthetics study results with no revenue or guidance weight, and no price trend is available. High-impact US data due shortly is backdrop without a fixed direction for the stock.
News situation · 1 items / 30 D
1 of 1 straight from the issuer or regulator
Outlook for AbbVie Inc.
Direction, typical moves and upcoming dates from our own price, news and calendar data, recalculated on every visit. An assessment, not investment advice.
What drives it
- Positive Phase 4 HARMONY data in GLP-1 patients support the aesthetics franchise.
- A HALO interim analysis showed very high participant satisfaction with the company's HA injectables.
What argues against it
- Both studies are small and single-arm, so the results may not translate into higher product sales.
- The study presentations came with no revenue figures, sales data or guidance change.
- High-impact US data due in the coming days could add broad market swings, with no set direction for ABBV.
What would change the picture
- Larger aesthetics trials or commercial data for the franchise would give the study results real weight.
- A clear surprise in upcoming US data, either way, could shift the broader market backdrop.
- Any company announcement with revenue or guidance implications would give the picture a firmer direction.
Coming up
- US: Retail sales · expected 0.7%, previous 0.9%
- US: EIA Crude Oil Stocks Change · expected -0.309M, previous 4.657M
- US: Jobless claims, Philadelphia Fed Manufacturing Index · expected 32.2, previous 20.9
Economic data for ABBV
Full calendarComing up
- TomorrowUSDCore Retail Sales m/m●●●Forecast 0.7%Previous 0.9%in 21h
- TomorrowUSDRetail Sales m/m●●●Forecast 0.3%Previous 0.8%in 21h
- November 18, 2026USDEIA Crude Oil Stocks Change●●●Forecast -0.309MPrevious 4.657Min 1 day
- November 19, 2026USDInitial Jobless Claims●●●in 2 days
- November 19, 2026USDPhiladelphia Fed Manufacturing Index●●●Forecast 32.2Previous 20.9in 2 days
- November 20, 2026USDMichigan Consumer Sentiment●●●Forecast 51.0Previous 51.0in 3 days
All times UTC. Assessed against the consensus forecast, otherwise against the previous value.
Both worlds over time
Technical and news signals of the last 90 days on one timeline.
What is being reported about ABBV
Frequently asked questions about AbbVie Inc.
What did AbbVie's new aesthetics data show?
At a recent dermatology meeting the company presented Phase 4 HARMONY results in GLP-1 patients, with a clear improvement in patient-reported facial outcomes, and a HALO interim analysis showing very high satisfaction with its HA injectables. Both were small studies, and neither carried revenue figures or a guidance change.
Do the aesthetics study results change the investment case?
Not much on their own. They support the Allergan Aesthetics franchise and could help demand for the injectables, but with cohorts of 30 and 25 participants and no financial data attached, the market impact is routine at most. Larger trials or actual sales figures would carry more weight.
What would give ABBV a clearer direction?
Two things: company news with financial weight, such as sales figures, guidance or a larger trial readout, and the market's reaction to the run of US economic releases. Either could tilt the currently balanced picture one way or the other.
📝 Overview Generated automatically
ABBV has been the subject of 27 signals across 27 articles in the last 365 days. Sentiment skews Neutral (56%).
Breakdown: 11 bullish, 1 bearish, 15 neutral.
Most-cited catalysts: Relfydess rejection removes a competitor (1×), Q2 2026 earnings beat (1×), Botox sales revival (1×). Most-cited risk factors: Other competitors may still threaten Botox (1×), FDA could approve other Botox alternatives soon (1×), Competitive threats to Botox from new entrants (1×).
Related assets
Same category or comparable signal picture — each card opens the full cockpit.